Enhanced security measures regarding data access management have been announced on the website of the US National Institutes of Health (NIH) Office of the Director, according to reports from several Chinese media outlets.

Starting last Friday (4th), institutions from China, Russia, Iran, and other countries of concern are banned from accessing NIH's controlled access data repositories and related data, which, as indicated by the reports, include key data platforms such as dbGaP and AnVIL.

Related NewsCCBI Lifts CSPC PHARMA (01093.HK) TP to $6.5, Keeps Rating at Neutral
Pharma stocks experienced a rout. WUXI BIO (02269.HK)  -0.250 (-1.004%)    Short selling $87.14M; Ratio 11.575%   and WUXI XDC (02268.HK)  +0.700 (+1.707%)    Short selling $7.94M; Ratio 4.495%   plummeted 17.7% and 20.4%. AKESO (09926.HK)  +0.300 (+0.366%)    Short selling $71.65M; Ratio 10.744%   , INNOVENT BIO (01801.HK)  +0.850 (+1.176%)    Short selling $121.31M; Ratio 6.982%   , BEIGENE (06160.HK)  +1.200 (+0.775%)    Short selling $28.26M; Ratio 3.920%   , 3SBIO (01530.HK)  +0.760 (+3.909%)    Short selling $242.45M; Ratio 20.077%   , and XTALPI-P (02228.HK)  -0.040 (-0.835%)    Short selling $10.95M; Ratio 3.052%   plunged 13.6-15.1%. WUXI BIO (02269.HK)  -0.250 (-1.004%)    Short selling $87.14M; Ratio 11.575%   , CSPC PHARMA (01093.HK)  +1.000 (+12.723%)    Short selling $780.41M; Ratio 19.653%   , SINO BIOPHARM (01177.HK)  +0.020 (+0.442%)    Short selling $125.43M; Ratio 16.275%   , EVEREST MED-B (01952.HK)  +0.200 (+0.421%)    Short selling $9.72M; Ratio 6.923%   , and GENSCRIPT BIO (01548.HK)  +1.180 (+8.780%)    Short selling $71.78M; Ratio 10.944%   eroded 9-11.9%.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-06 16:25.)